Cargando…

Active removal of anterior segment-migrated dexamethasone implant (Ozurdex(®))

Background: Ozurdex(®) (Allergan plc., Dublin, Ireland) is an intravitreal sustained-release dexamethasone (DEX) implant. The implant has been reported to migrate into the anterior chamber, potentially causing corneal decompensation. Prompt removal or relocation in the vitreous cavity is advised but...

Descripción completa

Detalles Bibliográficos
Autores principales: Depla, Jozef Adelson M., Veckeneer, Marc, Bleyen, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006423/
https://www.ncbi.nlm.nih.gov/pubmed/35465301
http://dx.doi.org/10.3205/oc000195

Ejemplares similares